Taking position: Effect of SGLT2i on arterial pressure, vascular damage, kidney disease and associated cardiovascular risk

被引：0

作者：

Inserra, Felipe ^{[1
,2
,3
,4
]}

Forte, Ezequiel ^{[5
]}

Elbert, Alicia ^{[6
]}

Waisman, Gabriel ^{[1
]}

Castellaro, Carlos ^{[3
]}

Buso, Carlos ^{[5
]}

Fairman, Enrique ^{[5
]}

Cobo, Augusto Lavalle ^{[5
]}

Manucha, Walter ^{[5
]}

Salmeri, Emiliano ^{[5
]}

Sanabria, Hugo ^{[5
]}

Sanchez, Ramiro ^{[5
]}

Terns, Paula Perez ^{[5
]}

Aranguren, Florencia ^{[6
]}

Arias, Pablo ^{[6
]}

Castano, Yanina ^{[6
]}

De Marziani, Guillermo ^{[6
]}

Faingold, Cristina ^{[6
]}

Gonzalez, Joaquin ^{[6
]}

Jawerbaum, Alicia ^{[6
]}

Vazquez, Fabiana ^{[6
]}

Wappner, Diego ^{[6
]}

Zaidel, Ezequiel J. ^{[6
]}

Aiello, Ernesto A. ^{[1
]}

Alfie, Jose ^{[1
]}

De Cerchio, Alejandro ^{[1
]}

Choi, Marcelo ^{[1
]}

Marquez, Diego ^{[1
]}

Piskorz, Daniel ^{[1
]}

Pupi, Luis Maria ^{[1
]}

Renna, Nicolas ^{[1
]}

Salazar, Martin ^{[1
]}

Dorado, Enrique ^{[3
]}

Ferder, Leon ^{[3
]}

Lavenia, Gustavo ^{[3
]}

Orias, Marcelo ^{[3
]}

Paganti, Luciana Gonzalez ^{[3
]}

Rigo, Diego H. ^{[3
]}

Diez, Guillermo Rosa ^{[3
]}

Sivak, Leonardo ^{[3
]}

Trimarchi, Hernan ^{[3
]}

Majul, Claudio ^{[5
]}

Sinay, Isaac ^{[5
]}

Marin, Marcos ^{[5
]}

Bonanno, Carlos ^{[5
]}

机构：

[1] Soc Argentina Hipertens Arterial, Buenos Aires, Argentina

[2] Com Salud Renal & Hipertens Arterial & Dano Vasc, Buenos Aires, Argentina

[3] Soc Argentina Nefrol, Buenos Aires, Argentina

[4] Univ Austral, Mecan Vasc Hipertens Arterial, Buenos Aires, Argentina

[5] Soc Argentina Cardiol, Buenos Aires, Argentina

[6] Soc Argentina Diabet, Buenos Aires, Argentina

来源：

REVISTA DE NEFROLOGIA DIALISIS Y TRASPLANTE | 2024年 / 44卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：49 / 51

页数：3

共 50 条

[41] The effect of taking blood pressure lowering medication at night on cardiovascular disease risk. A systematic review
Ho, Chau L. B.
Chowdhury, Enayet K.
Doust, Jenny
Nelson, Mark R.
Reid, Christopher M.
JOURNAL OF HUMAN HYPERTENSION, 2021, 35 (04) : 308 - 314
[42] PROVIDER-REPORTED BARRIERS TO GUIDELINE-DIRECTED UTILIZATION OF SGLT2I/GLP-1RA AGENTS AMONG PATIENTS WITH TYPE 2 DIABETES AT HIGH RISK FOR CARDIOVASCULAR DISEASE
Qian, Frank
Chaudhary, Richard
Jonas, Zachary
Ward, Charlotte
Moran, Sara
Quadir, Juweria
Chen, Zsu-Zsu
Benson, Mark D.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 1887 - 1887
[43] The effect of taking blood pressure lowering medication at night on cardiovascular disease risk. A systematic review
Chau L. B. Ho
Enayet K. Chowdhury
Jenny Doust
Mark R. Nelson
Christopher M. Reid
Journal of Human Hypertension, 2021, 35 : 308 - 314
[44] Urinary Biomarkers of Tubular Damage Are Associated with Mortality but Not Cardiovascular Risk among Systolic Blood Pressure Intervention Trial Participants with Chronic Kidney Disease
Jotwani, Vasantha K.
Lee, Alexandra K.
Estrella, Michelle M.
Katz, Ronit
Garimella, Pranav S.
Malhotra, Rakesh
Rifkin, Dena E.
Ambrosius, Walter
Freedman, Barry I.
Cheung, Alfred K.
Raphael, Kalani L.
Drawz, Paul
Neyra, Javier A.
Oparil, Suzanne
Punzi, Henry
Shlipak, Michael G.
Ix, Joachim H.
AMERICAN JOURNAL OF NEPHROLOGY, 2019, 49 (05) : 346 - 355
[45] GLP-1 RAs and SGLT2-Is to Lower Glucose and Reduce the Risk of Cardiovascular and Diabetic Kidney Disease
Morrison, Leigh
Gabison, Jonathan
Oshman, Lauren
JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE, 2024, 37 (03) : 372 - 382
[46] Left ventricular global longitudinal strain is associated with cardiovascular risk factors and arterial stiffness in chronic kidney disease
Krishnasamy, Rathika
Hawley, Carmel M.
Stanton, Tony
Pascoe, Elaine M.
Campbell, Katrina L.
Rossi, Megan
Petchey, William
Tan, Ken-Soon
Beetham, Kassia S.
Coombes, Jeff S.
Leano, Rodel
Haluska, Brian A.
Isbel, Nicole M.
BMC NEPHROLOGY, 2015, 16
[47] Left ventricular global longitudinal strain is associated with cardiovascular risk factors and arterial stiffness in chronic kidney disease
Rathika Krishnasamy
Carmel M. Hawley
Tony Stanton
Elaine M. Pascoe
Katrina L. Campbell
Megan Rossi
William Petchey
Ken-Soon Tan
Kassia S. Beetham
Jeff S. Coombes
Rodel Leano
Brian A. Haluska
Nicole M. Isbel
BMC Nephrology, 16
[48] SGLT2i Is Associated with Lower Risk of Mortality and Heart Failure Compared with Other Glucose-Lowering Drugs: A Three-Country Analysis
Birkeland, Kre I.
Jorgensen, Marit E.
Carstensen, Bendix
Gulseth, Hanne L.
Thuresson, Marcus
Fenici, Peter
Bodegard, Johan
Norhammar, Anna
DIABETES, 2017, 66 : A322 - A322
[49] Chronic Kidney Disease and Associated Cardiovascular Risk Factors in Chinese with Type 2 Diabetes
Lou, Qing-Lin
Ouyang, Xiao-Jun
Gu, Liu-Bao
Mo, Yong-Zhen
Ma, Ronald
Nan, Jennifer
Kong, Alice
So, Wing-Yee
Ko, Gary
Chan, Juliana
Chow, Chun-Chung
Bian, Rong-Wen
DIABETES & METABOLISM JOURNAL, 2012, 36 (06) : 433 - 442
[50] Projecting the incidence and costs of major cardiovascular and kidney complications of type 2 diabetes with widespread SGLT2i and GLP-1 RA use: a cost-effectiveness analysis
Morton, Jedidiah, I
Marquina, Clara
Shaw, Jonathan E.
Liew, Danny
Polkinghorne, Kevan R.
Ademi, Zanfina
Magliano, Dianna J.
DIABETOLOGIA, 2023, 66 (04) : 642 - 656

← 1 2 3 4 5 →